Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax-Reference-Cited by-同舟云学术

Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax

Published:2024-09 Issue:5 Volume:42 Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Cordella Stefano¹,Giusti Davide¹,De Bellis Eleonora²,Dargenio Michelina³,Creti’ Federica¹,Lazzarotto Davide⁴^ORCID,Cattaneo Chiara⁵^ORCID,Fracchiolla Nicola Stefano⁶^ORCID,Piccini Matteo⁷,Forghieri Fabio¹^ORCID,Pagano Livio⁸,Candoni Anna¹

Affiliation:

1. Section of Hematology Department of Medical and Surgical Sciences Azienda Ospedaliero‐Universitaria di Modena University of Modena and Reggio Emilia Modena Italy

2. Division of Hematology ASUGI Trieste Italy

3. Division of Hematology Ospedale Vito Fazzi Lecce Italy

4. Division of Hematology and Stem Cell Transplantation ASUFC University of Udine Udine Italy

5. Section of Hematology Spedali Civili Brescia Italy

6. U.O. Oncoematologia Fondazione IRCCS Ca’ Granda OspedaleMaggiore Policlinico University of Milan Milan Italy

7. Division of Hematology Azienda Ospedaliero‐Universitaria Careggi Florence Italy

8. Division of Hematology Polo Onco‐Ematologico Fondazione Policlinico A. Gemelli‐IRCCS Università Cattolica del Sacro Cuore Rome Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3310

Reference10 articles.

1. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

2. Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia

3. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

4. Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies

5. Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax